Entry
Name
Zagociguat (USAN/INN)
Formula
C16H10F4N6
Exact mass
362.0903
Mol weight
362.28
Structure
Mol file KCF file DB search
Class
Cardiovascular agent
DG03006 Guanylate cyclase activator
Efficacy
Neurodegenerative diseases agent, Guanylate cyclase activator
Comment
Treatment of serious neurodegenerative disorders including mitochondrial disease, Alzheimer's disease (AD), and cognitive impairment associated with schizophrenia
Target
Pathway
Interaction
DDI search
Brite
Drug groups [BR:br08330 ]
Cardiovascular agent
DG03006 Guanylate cyclase activator
D12516 Zagociguat
Target-based classification of drugs [BR:br08310 ]
Enzymes
Lyases (EC4)
Phosphorus-oxygen lyases
GUCY1A
D12516 Zagociguat (USAN/INN)
GUCY1B
D12516 Zagociguat (USAN/INN)
BRITE hierarchy
Other DBs
LinkDB
All DBs
KCF data
Show ATOM 26
1 C8x C 18.0057 -15.6326
2 N5x N 15.7724 -15.7024
3 C8y C 16.1912 -16.9586
4 N4y N 17.5869 -16.9586
5 C8x C 16.8890 -14.7952
6 C8y C 15.5631 -18.2148
7 N5x N 16.2609 -19.4012
8 C8y C 17.6567 -19.4012
9 C8x C 18.3546 -18.1450
10 C1b C 14.1414 -18.1934
11 C8y C 13.4200 -19.4007
12 C8x C 12.0400 -19.3798
13 C8x C 11.3217 -20.5815
14 C8x C 12.0033 -21.8044
15 C8x C 13.3833 -21.8253
16 C8y C 14.1016 -20.6236
17 X F 15.4700 -20.6449
18 C8y C 18.3574 -20.5922
19 N4x N 17.8001 -21.8717
20 C8y C 18.8448 -22.7971
21 N5x N 20.0477 -22.0895
22 N5x N 19.7464 -20.7268
23 C1d C 18.7076 -24.2146
24 X F 17.4168 -24.8022
25 X F 19.8378 -25.0217
26 X F 18.7076 -25.6146
BOND 29
1 2 3 2
2 3 4 1
3 4 1 1
4 1 5 2
5 2 5 1
6 3 6 1
7 6 7 2
8 7 8 1
9 8 9 2
10 4 9 1
11 6 10 1
12 10 11 1
13 11 12 2
14 12 13 1
15 13 14 2
16 14 15 1
17 15 16 2
18 11 16 1
19 16 17 1
20 8 18 1
21 18 19 1
22 19 20 1
23 20 21 2
24 21 22 1
25 18 22 2
26 20 23 1
27 23 24 1
28 23 25 1
29 23 26 1